Clinical Trials Browser

Has results × Head and Neck Neoplasms × dostarlimab × Clear all

NCT04313504 2026-05-07

Study Evaluating the Efficacy of Niraparib and Dostarlimab (TSR-042) in Recurrent/Metastatic HNSCC

Phase 2 Completed

10 enrolled 9 charts

Head and Neck Neoplasms